arrow_back Back to App

Tax exclusion for clinical trial payments and federal benefit protection.

New rules exclude payments for participating in approved clinical trials from taxable income. Additionally, these payments will not be considered when determining eligibility for federal benefits, potentially helping those in need access important assistance programs.
Key points
Money received for participating in clinical trials will not be counted as taxable income.
Payments for clinical trial participation will not affect eligibility for federal assistance programs, such as benefits or financial aid.
Changes apply to payments received after December 31, 2025.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_4184
Sponsor: Rep. Kelly, Mike [R-PA-16]
Process start date: 2025-06-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4184.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-06-26.

What are the main provisions?

Key points include:

  • Money received for participating in clinical trials will not be counted as taxable income.
  • Payments for clinical trial participation will not affect eligibility for federal assistance programs, such as benefits or financial aid.
  • Changes apply to payments received after December 31, 2025.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kelly, Mike [R-PA-16].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Ways and Means.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Taxes Health Benefits